The 2009 CCS/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascuar disease in the adult
(Can J Cardiol Vol 25 No 10 October 2009) recommends targeting LDL reduction to ≥ 50% when treating any level of cardiovascular risk
with pharmacotherapy. Initiation thresholds vary depending on level of risk and presence of risk modifiers.
This chart is available for download as a PDF in the Downloads section.
| Version 2.0, January 2013
This site complies to the HONcode standard for trustworthy health
information: verify here.